Physical Test for Distant Metastases in Patients with Breast Cancer
Open Access
- 1 September 1980
- journal article
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 73 (9), 617-623
- https://doi.org/10.1177/014107688007300904
Abstract
Of 312 patients presenting with breast cancer to a single clinic, 297 were screened for metastases in skin and nodes, bone, marrow, liver and lungs, using standard clinical, radiological scanning and cytological techniques. Thirty-four patients were found to have overt metastatic disease using these tests. Metastases were demonstrable on chest X-ray in 6.1% of the entire group of patients, on the bone scan in 4.2%, liver scan in 1.5%, liver ultrasound in 1.2% and in the bone marrow in only a single patient; 3.8% had contralateral or supraclavicular lymph node metastases or skin metastases. Twenty-eight of these 34 patients (82%) with overt metastases would have been classed as metastatic had only chest X-ray and clinical examination been carried out. A survey was then carried out to determine when tests for bone and liver metastases became abnormal. Bone scan and skeletal survey results were reviewed in 58 patients, 22 of whom had developed skeletal metastases and all of whom had regular skeletal scintigraphy carried out. Sixteen of 20 (80%) scans carried out within six months of the development of skeletal deposits were abnormal compared with 4 of 19 (21%) scans at the same follow-up time in those who failed to develop metastases, but few patients showed definite evidence of bone metastases on scanning prior to radiological metastases. Fifty-one patients who were found to have liver metastases at post-mortem were reviewed and most showed progressively rising alkaline phosphatase before death but only 11 of 57 (19.2%) and 14 of 50 (28%) had positive liver scintiscans and liver ultrasound examinations respectively from 3–12 months before death.Keywords
This publication has 8 references indexed in Scilit:
- ASSESSMENT OF BIOCHEMICAL TESTS TO SCREEN FOR METASTASES IN PATIENTS WITH BREAST CANCER*1The Lancet, 1980
- Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External PhotoscanningNew England Journal of Medicine, 1978
- BIOCHEMICAL MARKERS IN HUMAN BREAST CANCERThe Lancet, 1977
- Organ Selectivity for Implantation Survival and Growth of B16 Melanoma Variant Tumor Lines 2JNCI Journal of the National Cancer Institute, 1976
- THE CURABILITY OF BREAST CANCERThe Lancet, 1975
- Grey scale echography in the diagnosis of intrahepatic diseaseJournal of Clinical Ultrasound, 1973
- Skeletal metastases and mammary cancer.1972
- A co-ordinate transfer system for the Pho Gamma III Nuclear Chicago gamma cameraThe British Journal of Radiology, 1969